Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

TLR2 is crucial for hair growth and regeneration, and boosting it can help prevent hair loss.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

RTA 408 cream protects mice from radiation skin damage.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.